loading
前日終値:
$98.19
開ける:
$98.99
24時間の取引高:
419.86K
Relative Volume:
0.92
時価総額:
$4.65B
収益:
$291.49M
当期純損益:
$-308.55M
株価収益率:
-21.78
EPS:
-4.53
ネットキャッシュフロー:
$-168.02M
1週間 パフォーマンス:
+5.91%
1か月 パフォーマンス:
+6.80%
6か月 パフォーマンス:
+28.51%
1年 パフォーマンス:
+64.19%
1日の値動き範囲:
Value
$96.79
$99.30
1週間の範囲:
Value
$90.86
$99.35
52週間の値動き範囲:
Value
$60.28
$105.00

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
名前
Axsome Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
(212) 332-3241
Name
住所
ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK
Name
職員
569
Name
Twitter
Name
次回の収益日
2024-12-12
Name
最新のSEC提出書
Name
AXSM's Discussions on Twitter

AXSM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AXSM 98.68 4.65B 291.49M -308.55M -168.02M -4.53
VRTX 450.97 116.38B 10.63B -479.80M -1.35B 13.33
REGN 738.00 82.09B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.14B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.25B 3.30B -501.07M 1.03B 11.54

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-03 開始されました Wells Fargo Overweight
2024-08-06 アップグレード BofA Securities Neutral → Buy
2024-07-22 開始されました Needham Buy
2024-04-29 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-03-19 開始されました Robert W. Baird Outperform
2024-02-06 開始されました UBS Buy
2024-01-25 開始されました RBC Capital Mkts Outperform
2023-12-13 開始されました Citigroup Buy
2023-08-08 アップグレード BofA Securities Underperform → Neutral
2023-01-05 開始されました Piper Sandler Neutral
2022-11-01 開始されました Loop Capital Buy
2022-09-07 再開されました Mizuho Buy
2021-08-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-06-10 開始されました Berenberg Buy
2021-01-08 開始されました Jefferies Buy
2020-12-16 開始されました Mizuho Buy
2020-09-29 開始されました BofA Securities Underperform
2020-09-10 開始されました Morgan Stanley Overweight
2020-04-28 繰り返されました H.C. Wainwright Buy
2020-04-14 開始されました Cowen Outperform
2019-12-30 繰り返されました H.C. Wainwright Buy
2019-12-17 繰り返されました H.C. Wainwright Buy
2019-12-16 繰り返されました Guggenheim Buy
2019-10-16 開始されました Guggenheim Buy
2019-09-18 開始されました William Blair Outperform
2019-05-28 開始されました SunTrust Buy
2019-05-23 繰り返されました H.C. Wainwright Buy
2019-04-08 開始されました SVB Leerink Outperform
2019-03-15 繰り返されました H.C. Wainwright Buy
2016-10-03 再開されました Brean Capital Buy
2015-12-15 開始されました Cantor Fitzgerald Buy
2015-12-14 開始されました Ladenburg Thalmann Buy
すべてを表示

Axsome Therapeutics Inc (AXSM) 最新ニュース

pulisher
Nov 22, 2024

Migraine Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Amgen, Teva Pharma, Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories - Barchart

Nov 22, 2024
pulisher
Nov 22, 2024

Migraine Market Forecasted to Surge in Coming Years, 2023-2032 - openPR

Nov 22, 2024
pulisher
Nov 21, 2024

Excessive Daytime Sleepiness Market to Witness Growth During the Forecast Period | Takeda, Theranexus, XW Pharma, Avadel, Axsome Therapeutics, Benevolent AI Bio - The Globe and Mail

Nov 21, 2024
pulisher
Nov 21, 2024

(AXSM) Long Term Investment Analysis - Stock Traders Daily

Nov 21, 2024
pulisher
Nov 21, 2024

Axsome Therapeutics' SWOT analysis: strong pipeline, sales growth boost stock outlook - Investing.com

Nov 21, 2024
pulisher
Nov 20, 2024

StockNews.com Upgrades Axsome Therapeutics (NASDAQ:AXSM) to "Hold" - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Royce & Associates LP Has $2.02 Million Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Sells 81,952 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Nov 19, 2024
pulisher
Nov 17, 2024

Is It Too Late to Buy Viking Therapeutics Stock? - The Motley Fool

Nov 17, 2024
pulisher
Nov 15, 2024

FY2024 EPS Estimates for AXSM Increased by Leerink Partnrs - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript - AOL

Nov 14, 2024
pulisher
Nov 14, 2024

Axsome Therapeutics Inc (AXSM) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Axsome Advances Sleep Disorder Pipeline as Sunosi Prescriptions Increase in Q3 - Sleep Review

Nov 14, 2024
pulisher
Nov 14, 2024

Equities Analysts Offer Predictions for AXSM FY2027 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

William Blair Issues Pessimistic Outlook for AXSM Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Axsome stock price target increased, rating held on strong sales - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Axsome stock price target increased, rating held on strong sales By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Axsome Therapeutics stock hits 52-week high at $98.61 By Investing.com - Investing.com Nigeria

Nov 13, 2024
pulisher
Nov 13, 2024

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Robert W. Baird Raises Axsome Therapeutics (NASDAQ:AXSM) Price Target to $116.00 - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Axsome Therapeutics reports record quarterly revenue By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Versor Investments LP Acquires New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics’ Strong Q3 Growth Amidst Strategic Expansions - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

Earnings call: Axsome Therapeutics reports record quarterly revenue - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics stock hits 52-week high at $98.61 - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome shares rise as Guggenheim lifts target to $135 By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics Q3 Earnings: Stay For Near Term Catalysts, Then Sell (AXSM) - Seeking Alpha

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics (NASDAQ:AXSM) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics Inc earnings beat by $0.04, revenue topped estimates - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics' (AXSM) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Truist maintains buy on Axsome with $150 target on strong Auvelity sales - Investing.com UK

Nov 12, 2024
pulisher
Nov 10, 2024

(AXSM) Proactive Strategies - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 10, 2024

Privium Fund Management B.V. Grows Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Position Decreased by Lindbrook Capital LLC - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024 - GlobeNewswire

Nov 08, 2024
pulisher
Nov 08, 2024

Axsome Therapeutics to Present Breakthrough CNS Data Across 3 Major Disorders at NEI 2024 | AXSM Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 05, 2024

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Axsome Therapeutics (AXSM) to Release Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Position Trimmed by abrdn plc - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Assenagon Asset Management S.A. Lowers Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Nov 04, 2024
pulisher
Nov 01, 2024

Analysts Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) Target Price at $124.64 - MarketBeat

Nov 01, 2024

Axsome Therapeutics Inc (AXSM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):